PBS updates

Lax-Tab (Bisacodyl)

bisacodyl 5 mg enteric tablet, 200 · ORAL · PBS code 14446H

RESTRICTED

What it costs

AU$5.99 PBS-determined price per 400 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2024-09-01.
  • • Repeats: 2.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Constipation


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must be paraplegic or quadriplegic or have severe neurogenic impairment of bowel function.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Constipation


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must be receiving long-term nursing care on account of age, infirmity or other condition in a hospital, nursing home or residential facility.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Constipation


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must be receiving long-term nursing care and in respect of whom a Carer Allowance is payable as a disabled adult.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Constipation


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must be receiving palliative care.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Terminal malignant neoplasia


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Anorectal congenital abnormalities


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Megacolon


The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.

Sponsor: AFT Pharmaceuticals (AU) Pty Ltd ABN 29 105 636 413

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.